Skip to main content

Pharmacy

By Susan Morse | 02:36 pm | October 18, 2016
Medicare drug plan enrollees face 9 percent premium increase unless they switch plans during open enrollment.
By Kaiser Health News | 10:28 am | October 12, 2016
Spending was driven by increases in drug unit prices rather than an increase in the volume of drugs used, report says.
By Susan Morse | 04:27 pm | October 10, 2016
FDA approved drug Exondys 51 made by Sarepta Therapeutics to treat Duchenne muscular dystrophy.
By Susan Morse | 11:44 am | October 06, 2016
Prescription drug model meant to avoid adverse risk of medications, lower costs.
By Beth Jones Sanborn | 10:51 am | October 06, 2016
Founder Elizabeth Holmes said the company will close its clinical labs and Theranos Wellness Centers in Arizona, California and Pennsylvania.
By Kaiser Health News | 09:55 am | October 03, 2016
Since the medicine generally expires every year, the cost to replace EpiPens adds up fairly quickly, especially for consumers who do not have insurance or have high-deductible plans.
By Kaiser Health News | 09:34 am | October 03, 2016
Naltrexone and acamprosate are the two drugs on the market for patients with alcohol cravings.
By Kaiser Health News | 12:37 pm | September 30, 2016
The ticket, known as a rare pediatric disease priority review voucher, is part of a program created by Congress in 2007 to encourage the development of drugs for tropical diseases and later expanded to rare pediatric disorders.
By Kaiser Health News | 11:21 am | September 29, 2016
Views come as the skyrocketing prices of some drugs are under intense scrutiny, with new evidence showing massive price hikes by some companies.
By Jeff Lagasse | 02:54 pm | September 21, 2016
Gradual price hikes, growth in users pushes up spending for the federal prescription drug program.